Description
Immune-modulating antibodies in head and neck cancer: past, present, and future
Article: Immune-modulating antibodies in head and neck cancer: past, present, and future
€3.03
Related products
-
Article: Highlights in squamous cell carcinoma of the head and neck
€3.03 Add to cart -
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€3.03 Add to cart -
Article: Highlights in breast cancer
€3.03 Add to cart -
1 year subscription print edition of the Belgian Journal of Hematology (BJH)
€209.83 Add to cart
